Kathleen A Boyd Selected Research

Adjuvant Chemotherapy

12/2019	3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT.
11/2018	SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kathleen A Boyd Research Topics

Disease

3	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 11/2018
1	Hypercholesterolemia 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Tobacco Use Disorder (Nicotine Dependence) 11/2021
1	Premature Birth (Birth, Premature) 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 10/2015
1	Viral Bronchiolitis 09/2015
1	Cough 09/2015
1	Acquired Immunodeficiency Syndrome (AIDS) 02/2011

Drug/Important Bio-Agent (IBA)

3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 11/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	CholesterolIBA 01/2022
1	Antidepressive Agents (Antidepressants)IBA 11/2021
1	Indicators and Reagents (Reagents)IBA 11/2021
1	Fibronectins (Fibronectin)IBA 01/2021
1	AndrogensIBA 10/2015
1	Oxygen (Dioxygen)IBA 09/2015

Therapy/Procedure

3	Therapeutics 01/2022 - 10/2015
2	Nicotine Replacement Therapy 11/2021 - 02/2011
2	Drug Therapy (Chemotherapy) 01/2021 - 12/2019
2	Adjuvant Chemotherapy 12/2019 - 11/2018
1	Combination Drug Therapy (Combination Chemotherapy) 11/2018
1	Cryotherapy (Therapy, Cold) 10/2015